Detrol Sales Potential Could Be $1 Bil. With Once-Daily Indication, P&U Says

14 Feb 2000

• By The Pink Sheet

The sales potential of Pharmacia & Upjohn's overactive bladder treatment Detrol (tolterodine) could be up to half a billion dollars greater than previous projections, pending approval of a once-daily formulation.

Detrol Sales Potential Could Be $1 Bil. With Once-Daily Indication, P&U Says

More from Archive

More from Pink Sheet